Thank you all for an extraordinary 2023! We are grateful to our trusted partners, colleagues, followers, and friends!
For Evnia, it has been a year of growth and rediscovery of our core values of ‘’filotimo’’, creativity, hard work, and service to the community!
2023 highlights!
- A new office in London, UK, and a new operational branch to offer UK Representation Services!
- A new service for PMCF Registries
- A new operational branch dedicated to real-world evidence
- Guided >15 medtech & biotech start-ups towards market-access to both Europe and USA!
- Reached a new record of clinical evaluation reports with minimal, minor findings!
- Received 100% positive feedback received via our end-of-project satisfaction surveys
- Won Borsen’s Gazelle award 2023!
- Became a voting member of Denmark’s Trial Nation!
- Nominated as the top Medical Device Consulting company in Denmark for 2023!
- Completed another ISO 9001:2015 audit with zero findings for our Clinical and Regulatory Affairs Departments and our Authorised Representative operational branch!
- Significant investments in the onboarding and continuous training of new team members to support our new services!
- Our corporate responsibility efforts were maximized: support of NGOs such as Solsikkeprogrammet – The Hidden Disabilities Sunflower Scheme, ANIMA, Danish Hospital Clowns “Danske Hospitalsklovne“, funding of Evnia’s Antarctica project, scholarships, etc!
- Sponsored several international networking events helping promote knowledge and understanding of the changing Regulations!
Want to know what’s coming up in 2024? Stay tuned to our social media and website.
Evnia’s offices in Copenhagen, Aarhus, London, Siena, and Thessaloniki will be closed until Jan 3rd.
Merry and Bright Christmas! Happy Holidays everyone!
